COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Objective. To investigate biomarker patterns in rheumatoid arthritis (RA) with extraarticular manifestations. Methods. Cartilage oligomeric matrix protein (COMP), COMP-C3b, and soluble terminal complement complexes (sTCC) were measured by ELISA. Results. COMP-C3b levels were higher in patients with RA than in healthy controls and lower in extraarticular RA (ExRA) than in RA controls. In patients with ExRA, sTCC levels were higher than in RA controls, and correlated inversely with serum COMP-C3b levels in the ExRA group. Conclusion. Patients with ExRA had lower levels of COMP-C3b. This may be a consequence of complement consumption or a lower potential for COMP from these patients to activate complement. The Journal of Rheumatology Copyright © 2013. All rights reserved.

Cite

CITATION STYLE

APA

Happonen, K. E., Saxne, T., Jacobsson, L., Sturfelt, G., Rönnelid, J., Mollnes, T. E., … Blom, A. M. (2013). COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations. Journal of Rheumatology, 40(12), 2001–2005. https://doi.org/10.3899/jrheum.130613

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free